Bo Wang ✓

@BoWang87 · San Francisco, CA · joined 13 Sep 2016

Prof @UofT | Co-Founder & Chief AI Scientist @Xaira_Thera | Building first Virtual Cell | AI & Bio & Healthcare | Co-Inventor of ScGPT, MedSAM, BIOREASON

30 826Followers

3 241Following

2 138Posts total

951.7KViews on collected posts

Últimas publicaciones

Bo Wang ✓@BoWang876 Sep

Astra seems to be a step change in reasoning capabilities! Impressive! 3.3K views · 17 likes · 4 reposts · 0 replies Open on X →

Bo Wang ✓@BoWang876 Sep

Astra is shockingly good in reasoning! I benchmarked it on induction, and it almost saturated it with 88%. Fable 5.1, by comparison, is at 33%. The final numbers will actually go up: I am running a residual batch run on the non-evaluable; the results here reflect one batch run h 102.2K views · 415 likes · 50 reposts · 15 replies Open on X →

Bo Wang ✓@BoWang873 Sep

AGI is here and it is a looped model! 3.8K views · 17 likes · 2 reposts · 2 replies Open on X →

Bo Wang ✓@BoWang8726 Aug

Daraxonrasib approved! 🔥🔥 https://t.co/iIvO2hbj3e 3.1K views · 8 likes · 2 reposts · 2 replies Open on X →

Bo Wang ✓@BoWang8723 Aug

ARCH Venture Partners just topped the first fully data-driven biotech VC ranking : 1,992 points, nearly 25% ahead of #2 OrbiMed. The interesting signal: AI-driven companies are anchoring rankings at a pace the methodology wasn't designed to capture. Xaira is one of the portfolio 11.7K views · 88 likes · 14 reposts · 3 replies Open on X →

Bo Wang ✓@BoWang8720 Aug

Moderna/Merck just ran a 1,137-patient Phase 3 trial where every single dose was unique to that patient's tumor. It worked. The pipeline: surgical resection → whole exome + RNA sequencing → ML neoantigen ranking → mRNA encoding up to 34 patient-specific targets → 275K views · 1.9K likes · 339 reposts · 65 replies Open on X →

Bo Wang ✓@BoWang8720 Apr

Pancreatic cancer has one of the most suppressive tumor microenvironments in oncology. But two pancreatic cancer results dropped today. Both matter. 1. BioNTech mRNA neoantigen vaccine: nearly all responders still alive at 6 years. 98% of induced T cells were de novo — the http 552.6K views · 7.3K likes · 1.7K reposts · 121 replies Open on X →

Frente a cuentas del mismo tamaño

6 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. llega a mucha gente, pero pocos de esos espectadores reaccionan.

Visualizaciones medianas7 784esta cuenta916mediana de 10K–100K

Alcance, %25.25%esta cuenta3.48%mediana de 10K–100K

Interacción, %0.60%esta cuenta1.95%mediana de 10K–100K

Métrica	Esta cuenta	Mediana de 10K–100K	Proporción
Visualizaciones medianas por publicación	7 784	916	8.50×
Alcance (visualizaciones ÷ seguidores)	25.25%	3.48%	7.26×
Tasa de interacción	0.60%	1.95%	0.31×

Otras cuentas de este rango → Comparar con otra cuenta → Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

552.6K20 Apr

275K20 Aug

11.7K23 Aug

3.1K26 Aug

3.8K3 Sep

102.2K6 Sep

3.3K

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.68%20 Apr

0.83%20 Aug

0.91%23 Aug

0.39%26 Aug

0.55%3 Sep

0.48%6 Sep

0.64%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.95%.

What the audience does

Likes75.4%9 745 in total

Reposts16.3%2 102 in total

Replies1.6%208 in total

Quotes1.4%184 in total

Bookmarks5.3%680 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.